Abcuro

Developer of immune-modulatory bio-therapeutics for autoimmune diseases and cancer

placeNewton, Massachusetts, United States calendar_todayFounded 2015 groups24 employees language abcuro.com

Registered entities

Social engagement

Social engagement: 4.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

22 investors on record; lead investors include ShangPharma Innovation, Kaitai Capital Management, Sanofi Ventures, Mass General Brigham Ventures.

Investor typeCountShare
Venture capital1150%
Private equity15%
Accelerator & incubator15%
Other / undisclosed941%

Recent activity

16 Mar 2026
Event
Global Conference on Myositis (GCOM)
4 Nov 2025
Recognition
3 Nov 2025
Event
American Society of Hematology (#ASH) Annual Meeting and Exposition
Coming soon